← Back to all news
arXiv Machine Learning By Maria B{\aa}nkestad, Sandra Barman, Magnus R\"oding, Erik Kaunisto, Viktoriia Meklesh, Audrey Gallud, Marco Mendez, Marianna Yanez Arteta, Stefan Norberg, Ann Terry, Smita Chakraborty, Shun Yu, Jerk R\"onnols, Sepideh Pashami

A differentiable machine learning small-angle X-ray scattering analysis framework for structure elucidation of lipid nanoparticles

Read the original on arXiv Machine Learning →

arXiv:2606. 05200v1 Announce Type: cross Abstract: Lipid nanoparticles (LNPs) are efficient delivery systems for negatively charged nucleic acids.

Summary generated by The Flow from the publisher's feed. The full article lives at arXiv Machine Learning.

Related stories

arXiv Machine Learning
Jul 17

A Machine Learning Benchmarking Framework for Lipid Nanoparticle Transfection Efficiency Prediction

arXiv:2507. 03209v2 Announce Type: replace-cross Abstract: The discovery of new ionizable lipids for efficient lipid nanoparticle (LNP)-mediated RNA delivery remains a major bottleneck in RNA therapeutics development.

By Asal Mehradfar, Mohammad Shahab Sepehri, Jose Miguel Hernandez-Lobato, Glen S. Kwon, Mahdi Soltanolkotabi, Salman Avestimehr, Morteza Rasoulianboroujeni
efficiencybenchmarks
More like this →
arXiv Machine Learning
Jun 30

Inference-time optimization for experiment-grounded protein ensemble generation

arXiv:2602. 24007v3 Announce Type: replace-cross Abstract: Protein function relies on dynamic conformational ensembles, yet current generative models like AlphaFold3 often fail to produce ensembles that match experimental data.

By Advaith Maddipatla, Anar Rzayev, Marco Pegoraro, Martin Pacesa, Paul Schanda, Ailie Marx, Sanketh Vedula, Alex M. Bronstein
ragdiffusionbenchmarkssafety
More like this →
arXiv Machine Learning
Jun 5

An accurate nucleic acid-small molecule docking framework via geometric deep learning with large-scale pretraining

arXiv:2606. 05198v1 Announce Type: cross Abstract: Nucleic acids are increasingly recognized as therapeutic targets beyond conventional protein-centered drug discovery, yet accurate and efficient docking of small molecules to nucleic acid structures remains challenging.

By Shi Li (College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, P. R. China), Xujun Zhang (College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, P. R. China), Mingquan Liu (Faculty of Health Sciences, University of Macau, Macau SAR, China), Hui Zhang (College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, P. R. China, Shanghai Innovation Institute, Shanghai, China), Shuoying Jia (College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, P. R. China, Shanghai Innovation Institute, Shanghai, China), Yu Kang (College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, P. R. China, Shanghai Innovation Institute, Shanghai, China), Tingjun Hou (College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, P. R. China, Zhejiang Provincial Key Laboratory for Intelligent Drug Discovery and Development, Jinhua Institute of Zhejiang University, Zhejiang, China), Peichen Pan (College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, P. R. China, Zhejiang Provincial Key Laboratory for Intelligent Drug Discovery and Development, Jinhua Institute of Zhejiang University, Zhejiang, China)
fine-tuningbenchmarks
More like this →